Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Disorders of the Female Reproductive System01:24

Disorders of the Female Reproductive System

3.7K
The female reproductive system can be affected by several disorders, including Premenstrual Syndrome (PMS), Premenstrual Dysphoric Disorder (PMDD), endometriosis, and various forms of cancer. PMS and PMDD are cyclical conditions that cause physical and emotional distress, with symptoms that include edema, mood swings, and food cravings. PMDD is a more severe form of PMS characterized by increased symptom severity that peaks during the luteal phase and tends to improve or resolve shortly after...
3.7K
The Menstrual Cycle01:19

The Menstrual Cycle

2.4K
The menstrual cycle is a recurrent sequence of changes in the uterine endometrium, specifically its functional layer, the stratum functionalis. This cycle prepares the uterus for potential pregnancy. This cycle typically spans 21–35 days, averaging 28 days, and aligns with the ovarian cycle, regulated by fluctuating levels of ovarian hormones, primarily estrogen and progesterone.
The menstrual phase occurs from days 1 to 5 and involves the shedding of the stratum functionalis, as a...
2.4K
Hormonal Regulation of the Menstrual Cycle01:22

Hormonal Regulation of the Menstrual Cycle

1.2K
The ovarian cycle regulates endometrial changes throughout a single menstrual cycle via the coordinated action of gonadotrophin-releasing hormone (GnRH) and gonadotrophins.
At puberty, GnRH begins a pulsatile release pattern, which triggers the anterior pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). The frequency and amplitude of GnRH pulses vary across the menstrual cycle, with faster pulses favoring LH release and slower pulses favoring FSH...
1.2K
Menses Phase01:18

Menses Phase

855
The uterine cycle begins with the menstrual phase, which is considered day one of the cycle and typically lasts about five days. This phase is characterized by the degeneration and shedding of the stratum functionalis, the functional layer of the endometrium.
When fertilization does not occur, the corpus luteum deteriorates, causing a significant drop in the levels of estrogen and progesterone in the body. This hormonal decrease triggers the release of prostaglandins, which cause the uterine...
855
Ovarian Cycle01:27

Ovarian Cycle

2.9K
The menstrual cycle includes a critical component known as the ovarian cycle, which undergoes two main phases each month—the follicular phase and the luteal phase. The follicular phase is variable and averaging around 14 days. Ovulation, triggered by a surge in luteinizing hormone (LH), marks the transition between the two phases. The second phase, the luteal phase, is relatively consistent, lasting approximately 14 days, and is marked by the activity of the corpus luteum. While a cycle...
2.9K
Proliferative Phase01:20

Proliferative Phase

1.1K
The proliferative phase typically occurs after menstruation and lasts between 6 to 13 days in a standard 28-day cycle. This phase involves the reconstruction of the endometrium, guided by estrogen produced by the developing ovarian follicle.
Notably, the stratum basale, the basal layer of the endometrium, including the basal parts of the uterine glands, remains unaffected by menstruation. Stem cells in this layer undergo mitosis, regenerating the stratum functionalis and thickening the...
1.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Evidence for actions of estrone distinct from those of estradiol.

The Journal of clinical endocrinology and metabolism·2026
Same author

Obesity in menopause care.

European journal of endocrinology·2026
Same author

European society of endocrinology clinical practice guideline for evaluation and management of menopause and the perimenopause.

European journal of endocrinology·2025
Same author

Medical treatment of fibroids: FIGO best practice guidance.

International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics·2025
Same author

NICE guidelines on menopause are missing nuance.

BMJ (Clinical research ed.)·2025
Same author

NK3 receptor antagonist alters the centrally controlled perception of menopausal flushing - a pilot study.

Climacteric : the journal of the International Menopause Society·2025

Related Experiment Video

Updated: Dec 14, 2025

Ex Vivo Method for Assessing the Mouse Reproductive Tract Spontaneous Motility and a MATLAB-based Uterus Motion Tracking Algorithm for Data Analysis
06:22

Ex Vivo Method for Assessing the Mouse Reproductive Tract Spontaneous Motility and a MATLAB-based Uterus Motion Tracking Algorithm for Data Analysis

Published on: September 1, 2019

9.4K

Progesterone and abnormal uterine bleeding/menstrual disorders.

Michaela Jewson1, Prashant Purohit2, Mary Ann Lumsden3

  • 1Obstetrics and Gynaecology, Greater Glasgow and Clyde, Glasgow, UK.

Best Practice & Research. Clinical Obstetrics & Gynaecology
|July 24, 2020
PubMed
Summary

Progesterone and progestogens effectively manage abnormal uterine bleeding (AUB) and heavy menstrual bleeding (HMB). These hormones also prevent endometrial hyperplasia and reduce cancer risk in menopausal women.

Keywords:
HRTMenopauseMenorrhagiaProgesteroneProgestogen

More Related Videos

Generation of Multicellular Human Primary Endometrial Organoids
09:20

Generation of Multicellular Human Primary Endometrial Organoids

Published on: October 4, 2019

11.5K
Herbs-Partitioned Moxibustion on the Navel in a Rat Model of Primary Dysmenorrhea with Cold Coagulation and Blood Stasis
05:36

Herbs-Partitioned Moxibustion on the Navel in a Rat Model of Primary Dysmenorrhea with Cold Coagulation and Blood Stasis

Published on: October 4, 2024

969

Related Experiment Videos

Last Updated: Dec 14, 2025

Ex Vivo Method for Assessing the Mouse Reproductive Tract Spontaneous Motility and a MATLAB-based Uterus Motion Tracking Algorithm for Data Analysis
06:22

Ex Vivo Method for Assessing the Mouse Reproductive Tract Spontaneous Motility and a MATLAB-based Uterus Motion Tracking Algorithm for Data Analysis

Published on: September 1, 2019

9.4K
Generation of Multicellular Human Primary Endometrial Organoids
09:20

Generation of Multicellular Human Primary Endometrial Organoids

Published on: October 4, 2019

11.5K
Herbs-Partitioned Moxibustion on the Navel in a Rat Model of Primary Dysmenorrhea with Cold Coagulation and Blood Stasis
05:36

Herbs-Partitioned Moxibustion on the Navel in a Rat Model of Primary Dysmenorrhea with Cold Coagulation and Blood Stasis

Published on: October 4, 2024

969

Area of Science:

  • Reproductive endocrinology and gynecology

Background:

  • Abnormal uterine bleeding (AUB) and heavy menstrual bleeding (HMB) are common gynecological issues.
  • Progesterone and progestogens play crucial roles in the female reproductive system.

Purpose of the Study:

  • To explore the role of progesterone and progestogens in managing AUB.
  • To clarify best practices, benefits, and risks associated with progestogen use.
  • To explain progesterone's systemic effects and side effect management.

Main Methods:

  • Literature review and synthesis of current clinical practices.
  • Analysis of hormonal mechanisms in gynecological conditions.
  • Examination of progesterone's impact on various physiological systems.

Main Results:

  • Progestogens regulate intermenstrual bleeding and reduce HMB in reproductive and perimenopausal women.
  • Progesterone and progestogens prevent endometrial hyperplasia and decrease endometrial cancer risk in menopausal women.
  • Progesterone influences breast, cardiovascular, lipid, and bone health, with potential for beneficial or intended side effect management.

Conclusions:

  • Progesterone and progestogens are vital for managing AUB and HMB.
  • These hormones are essential for endometrial protection and cancer prevention in postmenopausal women.
  • Understanding progesterone's multifaceted effects is key for optimizing patient care and managing side effects.